
### [MONDO:0020312](http://purl.obolibrary.org/obo/MONDO_0020312)
**Label:** atypical chronic myeloid leukemia

**Subclasses:** [MONDO:0011996](http://purl.obolibrary.org/obo/MONDO_0011996) (chronic myelogenous leukemia), 

**Corr. equiv. classes:** [OMIM:608232](http://purl.obolibrary.org/obo/OMIM_608232), [Orphanet:521](http://www.orpha.net/ORDO/Orphanet_521), 

**Class expressions from DL-Learner:**

- [HP:0004848](http://purl.obolibrary.org/obo/HP_0004848) (Ph-positive acute lymphoblastic leukemia) 75.00%
- [HP:0001912](http://purl.obolibrary.org/obo/HP_0001912) (Abnormality of basophils) 75.00%
- [HP:0005558](http://purl.obolibrary.org/obo/HP_0005558) (Chronic leukemia) and [HP:0006721](http://purl.obolibrary.org/obo/HP_0006721) (Acute lymphoblastic leukemia) 75.00%
- [HP:0005506](http://purl.obolibrary.org/obo/HP_0005506) (Chronic myelogenous leukemia) and [HP:0006721](http://purl.obolibrary.org/obo/HP_0006721) (Acute lymphoblastic leukemia) 75.00%
- [HP:0004848](http://purl.obolibrary.org/obo/HP_0004848) (Ph-positive acute lymphoblastic leukemia) and [HP:0005558](http://purl.obolibrary.org/obo/HP_0005558) (Chronic leukemia) 75.00%
- [HP:0004848](http://purl.obolibrary.org/obo/HP_0004848) (Ph-positive acute lymphoblastic leukemia) and [HP:0005506](http://purl.obolibrary.org/obo/HP_0005506) (Chronic myelogenous leukemia) 75.00%
- [HP:0001428](http://purl.obolibrary.org/obo/HP_0001428) (Somatic mutation) and [HP:0006721](http://purl.obolibrary.org/obo/HP_0006721) (Acute lymphoblastic leukemia) 75.00%
- [HP:0001428](http://purl.obolibrary.org/obo/HP_0001428) (Somatic mutation) and [HP:0005506](http://purl.obolibrary.org/obo/HP_0005506) (Chronic myelogenous leukemia) 75.00%
- [HP:0001428](http://purl.obolibrary.org/obo/HP_0001428) (Somatic mutation) and [HP:0004848](http://purl.obolibrary.org/obo/HP_0004848) (Ph-positive acute lymphoblastic leukemia) 75.00%
- [HP:0000005](http://purl.obolibrary.org/obo/HP_0000005) (Mode of inheritance) and [HP:0005506](http://purl.obolibrary.org/obo/HP_0005506) (Chronic myelogenous leukemia) 75.00%
- [HP:0000005](http://purl.obolibrary.org/obo/HP_0000005) (Mode of inheritance) and [HP:0004848](http://purl.obolibrary.org/obo/HP_0004848) (Ph-positive acute lymphoblastic leukemia) 75.00%
- [HP:0005506](http://purl.obolibrary.org/obo/HP_0005506) (Chronic myelogenous leukemia) and (not ([HP:0100545](http://purl.obolibrary.org/obo/HP_0100545) (Arterial stenosis))) 75.00%
- [HP:0005506](http://purl.obolibrary.org/obo/HP_0005506) (Chronic myelogenous leukemia) and (not ([HP:0030680](http://purl.obolibrary.org/obo/HP_0030680) (Abnormality of cardiovascular system morphology))) 75.00%
- [HP:0005506](http://purl.obolibrary.org/obo/HP_0005506) (Chronic myelogenous leukemia) and (not ([HP:0025015](http://purl.obolibrary.org/obo/HP_0025015) (Abnormal vascular morphology))) 75.00%
- [HP:0005506](http://purl.obolibrary.org/obo/HP_0005506) (Chronic myelogenous leukemia) and (not ([HP:0012639](http://purl.obolibrary.org/obo/HP_0012639) (Abnormality of nervous system morphology))) 75.00%


